Welcome to NEXTGEN

Building healthy societies around the Globe

Who we are

We have unique internationally trained team backed by stellar educational and R&D credentials, strong intellectual property portfolio, innovative herbal and “green chemistry” products. We have proven leadership skills, knowledge of market dynamics, multiple Scientific Advisory Board and Board of Directors appointments, commitment to provide best service and corporate social responsibility to our clients, patients, clinicians, healthcare professionals and global community.


Dr. Param Singh

( CEO & Co-founder )

A professional agriculturalist-Entomologist and a seasoned entrepreneur with an extensive experience in global accredited platforms of R&D such as agricultural, herbal and medicinal products. He has over 25 years of experience in commercial products design and indent sourcing globally; the organic and natural sustainable fibres for infants and home industries.

Dr. Kulvinder Saini

( President & co-founder )

A highly acclaimed Biomedical Scientist and Entrepreneur with 30+ years of International R&D, Project Management and Operations experience in Pharma/Biotech Industry, Public Organisations, Renowned Teaching Hospitals and Academia in 4 culturally diverse countries-Australia, USA, India and Saudi Arabia. PhD-Animal Biochemistry from Sydney University, Australia. Postdoc-Case Western Med School, Cleveland, USA. Res. Fellow-Harvard Med School, Boston, USA.


Promoting holistic wellness, customised and personalised healthcare solutions

Herbal Medicine

Harnessing medicinal properties of various herbs/natural biodiversity and fortifying our diets to recharge / rejuvenate our bodies and innate defence / immune system with anti-cancer, anti-ageing, anti-viral, anti-bacterial and anti-fungal power.


NEXTGEN strives to provide in Australian, New Zealand and SE Asian markets with potentially therapeutic, medicinally and nutritionally functional foods and
Nanotechnology based scientific products. 

IMG-20210926-WA0002 (1)

APIs sourcing

Our Team will work with our Indian partners for global sourcing of key APIs to strengthen the Australian pharmaceuticals manufacturing ecosystem under Good Manufacturing Practices (GMP) conditions and produce personalised healthcare products.

Aspirin, also known as acetylsalicylic acid (ASA), was initially extracted from the bark and leaves of the willow tree. Now chemically synthesised, it is widely used for reducing pain, fever inflammation and a number of other ailments.  Aspirin given shortly after a heart attack decreases the risk of death. Aspirin is also prescribed long-term to help prevent further heart attacks, strokes, and blood clots.

Evidence suggests that aspirin may reduce overall cancer incidence and mortality in colorectal, oesophageal and gastric cancers, with smaller effects on other malignancies of the prostrate, breast and lung.
Despite being one of the safest medicine-Aspirin does not come without side effects. One common adverse reaction in few people could be an upset stomach and gastrointestinal bleeding, etc.

New Chemical Entities (NCEs)

Our team focuses on working on patented, new and novel NCEs and collaborating with international labs to generate safe, personalised and effective bio-active small molecule drugs against cancer, with minimal side effects, and importing/making Active Pharmaceuticals Ingredients
(APIs) for the Australian Pharmaceutical/Biotech companies.

WhatsApp Image 2021-09-23 at 12.59.49 PM

Cancer Diagnostics

We will keep our focus on Oncology for delivering effective diagnosis and prognosis biomarkers based on genomics and artificial intelligence to promote the well-being of cancer patients, improve quality of life by targeted therapies and build healthy and happy societies all around the globe.

Our Main Service

Lorem mauris tincidunt lacus, id rhoncus erat facilisis purus sed consectetur in.

Our Facilities

Nibh euismod massa ultrices sagittis, a tortor fermentum pulvinar interdum et ut.

Our Location

Midtown Manhattan
123 5th Ave, New York,
NY 1021, US.

Make An Appointment

Urna aliquet feugiat odio enim ut pharetra pretium velit viverra elementum pulvinar viverra diam urna rhoncus eu, et, malesuada luctus neque mollis morbi placerat.

Book an appoitnment

+1 123 444 5678

We Employ Latest Research Technology & Company

Pulvinar proin sit neque pellentesque elementum purus faucibus nunc tincidunt lorem sed posuere velit condimentum scelerisque varius tempor in amet cum pharetra malesuada nisl, urna congue faucibus rhoncus a ultrices nec at pulvinar convallis ac vitae amet condimentum risus pharetra rhoncus pretium consequat cras feugiat lorem nam non.

“Viverra nec consectetur dictum at pulvinar ac ornare sed a fringilla integer varius metus ac, cras purus vulputate ultrices amet, sit porta hac mattis.”

Alex Hobbs,

Founder, CEO of PointLab

of 5


1860 Reviews


1630 Reviews


2100 Reviews

Our Services

x1 (1)

The commercialisation of Australian technology

Very exciting developments are being carried out on food, fibre, small molecule oncology drugs and personalised cancer diagnostics. At NEXTGEN, we are dedicated to find operational partnerships to commercialise the innovation in our APAC markets.

Business Developement & Management Of Early-Stage Ventures

Our team aims to import APIs for small to medium local manufacturers and strengthen the capabilities of Australian entities in OTC and targeted pharma products. At NEXTGEN we are dedicated to provide services to start ups for commercialising novel ideas to documented innovations in global settings as well as scaling up of NCEs and APIs.

x3 (1)

Sustainable and competitive market entry strategy

We aim to deliver and promote the well-being of humankind that is sustainable, cost-effective and affordable.

x4 (1)

Establishment of effective team management and resource allocation teams

We understand each client has different needs. From our team of high calibre specialists, scientists and managers, we would provide you with a target-product focused R&D, personalised and tailored team for fulfilling your business objectives.


Biomedical Strategy Consultants

We work with you on small molecule drug discovery R&D, help you with alliance building, NCEs and APIs scale up, CRO work, pre-clinical studies, and phase-1 human clinical trials.


Other Services

We also work on global facilitation in the areas of indent importations, scaling up small molecule drugs/NCEs for pre-clinical studies & clinical trials, manufacturing and product launches at national and international markets.

Latest Case Studies

Imperdiet aliquet est vel nulla turpis eu consequat ullamcorper a egestas suspendisse faucibus eu velit, phasellus pulvinar lorem et libero et tortor, sapien nulla.

What People Say About Us

Elementum in lacus, fermentum dapibus magna lectus ut vel feugiat pellentesque molestie quam venenatis, tempor in.

Ethan Shaw
“Metus venenatis cursus ipsum egestas blandit accumsan est feugiat tempus dignissim ante nunc viverra nulla condimentum nunc in sit massa pulvinar tempor mi tortor sapien vel egestas odio bibendum sem ultrices tellus.”

PointLab Expert Team

Imperdiet aliquet est vel nulla turpis eu consequat ullamcorper a egestas suspendisse faucibus eu velit, phasellus pulvinar lorem et libero et tortor, sapien nulla.

Margaret Anderson

Head of Laboratory Department

Mark Anthony

Senior Pathologist

Samantha Wood

Laboratory Technician

Get One Step Ahead Of Disease

Imperdiet aliquet est vel nulla turpis eu consequat ullamcorper a egestas suspendisse faucibus eu velit, phasellus pulvinar lorem et libero et tortor, sapien nulla.


Subsribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Contact Us

Param Singh, PhD / Kulvinder Singh Saini, PhD

Call Us

(+61) 0415475960 / (+61) 0423554376

Email Us

param@nextgenpharma.com.au / kulvinder@nextgenpharma.com.au